Clinical Genetics
Pharmacogenomics
Genotype-guided prescribing and drug response variability.
Scientific context
Understanding the field
Work covers star-allele calling in pharmacogenes, implementation of prescribing guidance in clinical systems, and evaluation of clinical utility.
Pharmacogenomics investigates how inherited variation contributes to differences in drug metabolism, transport, targets and adverse effects. Implementation connects validated genotypes with carefully maintained prescribing guidance.
Central questions
- Which gene–drug relationships have sufficient clinical evidence?
- How should complex alleles be detected and reported?
Methodological framework
- Star-allele and copy-number calling
- Clinical implementation and decision-support evaluation
- Prospective outcomes and equity assessment
Relevance
Scientific and clinical value
For selected gene–drug pairs, high-quality evidence can support safer dose selection or alternative therapy alongside clinical factors and current guidelines.
Limits and responsibility
Genotype is only one determinant of drug response. Age, organ function, interactions, adherence and ancestry-sensitive assay performance remain essential; results require professional interpretation.
Authoritative resources
Public reference resources
These independent resources are provided for scholarly orientation; inclusion does not imply an institutional partnership. This page does not replace medical advice or diagnosis.